Journal of Human Reproductive Science
Home Ahead of Print Current Issue Archives
   Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size    Users online: 390
This article has been cited by
1Removal of DHT can relieve polycystic ovarian but not metabolic abnormalities in DHT-induced hyperandrogenism in mice
Li-Feng Sun,Ya-Li Yang,Tian-Xia Xiao,Meng-Xia Li,Jian V. Zhang
Reproduction, Fertility and Development.2019;31(10)1597
[DOI]
2Characterization of Reproductive, Metabolic, and Endocrine Features of Polycystic Ovary Syndrome in Female Hyperandrogenic Mouse Models
A. S. L. Caldwell,L. J. Middleton,M. Jimenez,R. Desai,A. C. McMahon,C. M. Allan,D. J. Handelsman,K. A. Walters
Endocrinology.2014;155(8)3146
[DOI]
3Polycystic ovary syndrome (PCOS) and endocrine disrupting chemicals (EDCs)
Eleni Palioura,Evanthia Diamanti-Kandarakis
Reviews in Endocrine and Metabolic Disorders.2015;16(4)365
[DOI]
4Polycystic ovary syndrome (PCOS) and endocrine disrupting chemicals (EDCs)
Anna Aronis
Reviews in Endocrine and Metabolic Disorders.2014;20144564(4)281
[DOI]
5Polycystic ovary syndrome with hyperandrogenism as a risk factor for non-obese non-alcoholic fatty liver disease
J. J. Kim,D. Kim,J. Y. Yim,J. H. Kang,K. H. Han,S. M. Kim,K. R. Hwang,S. Y. Ku,C. S. Suh,S. H. Kim,Y. M. Choi
Alimentary Pharmacology & Therapeutics.2017;45(11)1403
[DOI]
6Polycystic ovary syndrome with feasible equivalence to overweight as a risk factor for non-alcoholic fatty liver disease development and severity in Mexican population
Nicolás Salva-Pastor,Guillermo Nahúm López-Sánchez,Norberto Carlos Chávez-Tapia,Jorge Román Audifred-Salomón,Danniela Niebla-Cárdenas,Rafael Topete-Estrada,Helga Pereznuñez-Zamora,Rafael Vidaltamayo-Ramírez,Margarita Elodia Báez-Arellano,Misael Uribe,Natalia Nuño-Lámbarri
Annals of Hepatology.2020;19(3)251
[DOI]
7Fibroscan as a non-invasive predictor of hepatic steatosis in women with polycystic ovary syndrome
Semanti Chakraborty,MohdAshraf Ganie,Ibrahim Masoodi,Manisha Jana,Manisha Shalimar,Nandita Gupta,NighatYaseen Sofi
Indian Journal of Medical Research.2020;151(4)333
[DOI]
8MANAGEMENT OF ENDOCRINE DISEASE: Polycystic ovary syndrome and nonalcoholic fatty liver disease
Djuro Macut,Ivana Božic-Antic,Jelica Bjekic-Macut,Konstantinos Tziomalos
European Journal of Endocrinology.2017;177(3)R145
[DOI]
9Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome
Carly E Kelley
World Journal of Gastroenterology.2014;20(39)14172
[DOI]
10Caring for women with polycystic ovary syndrome
Katherine Pereira,Kathryn Evans Kreider
The Nurse Practitioner.2017;42(2)39
[DOI]
11A potential link between polycystic ovary syndrome and non-alcoholic fatty liver disease: an update meta-analysis
Jia Wu,Xin-Yu Yao,Ru-Xia Shi,Su-Fen Liu,Xiao-Yong Wang
Reproductive Health.2018;15(1)39
[DOI]
12Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis
A. L. L. Rocha,L. C. Faria,T. C. M. Guimarães,G. V. Moreira,A. L. Cândido,C. A. Couto,F. M. Reis
Journal of Endocrinological Investigation.2017;40(12)1279
[DOI]
13Insulin resistance and hyperandrogenemia independently predict nonalcoholic fatty liver disease in women with polycystic ovary syndrome
Sree Harsha Varma,Sunanda Tirupati,T.V.S. Pradeep,Vijaya Sarathi,Dileep Kumar
Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2019;13(2)1065
[DOI]
14Circulating osteopontin and its association with liver fat content in non-obese women with polycystic ovary syndrome: a case control study
Yuying Wang,Wei Zhou,Chunhua Wu,Yi Zhang,Tzuchun Lin,Yun Sun,Wei Liu,Tao Tao
Reproductive Biology and Endocrinology.2018;16(1)1065
[DOI]
15High-Fat Diet Induces Significant Metabolic Disorders in a Mouse Model of Polycystic Ovary Syndrome1
Hao Lai,Xiao Jia,Qiuxiao Yu,Chenglu Zhang,Jie Qiao,Youfei Guan,Jihong Kang
Biology of Reproduction.2014;91(5)1065
[DOI]
16Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges
Yvonne M. Jeanes,Sue Reeves
Nutrition Research Reviews.2017;30(1)97
[DOI]
17Are Women With Polycystic Ovarian Syndrome at a High Risk of Non-Alcoholic Fatty Liver Disease? A Meta-Analysis
Mahdi Ramezani Binabaj,Mohsen Motalebi,Hamid Karimi-Sari,Mohammad Saeid Rezaee Zavareh,Seyed Moayed Alavian
Hepatitis Monthly.2014;14(11)97
[DOI]
18NAFLD and Extra-Hepatic Comorbidities: Current Evidence on a Multi-Organ Metabolic Syndrome
Valerio Rosato,Mario Masarone,Marcello Dallio,Alessandro Federico,Andrea Aglitti,Marcello Persico
International Journal of Environmental Research and Public Health.2019;16(18)3415
[DOI]
19Evidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: a novel hepato-ovarian axis?
Giovanni Targher,Maurizio Rossini,Amedeo Lonardo
Endocrine.2016;51(2)211
[DOI]
20Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease
Andrew A. Li,Aijaz Ahmed,Donghee Kim
Gut and Liver.2020;14(2)168
[DOI]
21Reproductive Health and Nonalcoholic Fatty Liver Disease in Women: Considerations Across the Reproductive Lifespan
Monika Sarkar,Ayako Suzuki
Clinical Liver Disease.2020;15(6)219
[DOI]
22Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy
Seema Patel
The Journal of Steroid Biochemistry and Molecular Biology.2018;182(6)27
[DOI]
About us 
Editorial board 
Instructions 
Subscribe 
Search articles 
Contact us 
Advertise With Us
My Preferences 

Submit articles online
Email alerts
Join our team of reviewers
Most polular articles
Recommend this journal